Valuation Krka, d. d.

Stocks

End-of-day quote Ljubljana S.E. 2026-11-06			5-day change	1st Jan Change
244.00 ^EUR	-2.01%		-3.17%	+20.20%

07-23	Krka, d. d. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-20	Krka, d. d. commences an Equity Buyback for 3,279,344 shares, representing 10% of its issued share capital, under the authorization approved on July 9, 2026.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	3,676	2,857	3,402	4,274	6,184	7,388	-	-
Change	-	-22.28%	19.08%	25.64%	44.7%	19.46%	-	-
Enterprise Value (EV) ¹	3,373	2,338	3,228	3,929	5,836	6,785	6,733	6,679
Change	-	-30.68%	38.07%	21.73%	48.54%	16.26%	-0.78%	-0.8%
P/E	11.9x	7.87x	10.8x	12x	15.4x	17.3x	16.6x	15.7x
PBR	2.02x	1.41x	1.65x	2.04x	2.8x	3.09x	2.94x	2.81x
PEG	-	0.4x	-0.8x	0.8x	1.1x	2.54x	3.8x	2.97x
Capitalization / Revenue	2.35x	1.66x	1.88x	2.24x	3.03x	3.41x	3.22x	3.05x
EV / Revenue	2.15x	1.36x	1.79x	2.06x	2.86x	3.13x	2.94x	2.75x
EV / EBITDA	7.27x	4.78x	6.4x	7.55x	10.4x	10.9x	10.3x	9.75x
EV / EBIT	9.51x	6.13x	8.08x	9.19x	12.5x	13x	12.4x	11.7x
EV / FCF	10.5x	6.27x	36.7x	16x	13.6x	21.2x	18.2x	16.8x
FCF Yield	9.49%	16%	2.73%	6.25%	7.37%	4.73%	5.48%	5.96%
Dividend per Share ²	5	5.63	6.6	7.5	8.25	9.402	10.34	11.19
Rate of return	4.24%	6.12%	6%	5.4%	4.06%	3.85%	4.24%	4.59%
EPS ²	9.92	11.69	10.14	11.6	13.21	14.11	14.73	15.5
Distribution rate	50.4%	48.2%	65.1%	64.7%	62.5%	66.6%	70.2%	72.2%
Net sales ¹	1,566	1,717	1,806	1,910	2,041	2,165	2,294	2,424
EBITDA ¹	463.6	488.9	504.2	520.1	558.7	625.1	654.3	684.9
EBIT ¹	354.8	381.2	399.6	427.6	465.1	522	543.6	571.7
Net income ¹	309.2	363.3	313.9	357	403.2	434.1	457.1	478.8
Net Debt ¹	-303.1	-518.9	-174	-344.9	-347.8	-602.1	-654.8	-708.6
Reference price ²	118.00	92.00	110.00	139.00	203.00	244.00	244.00	244.00
Nbr of stocks (in thousands)	31,152	31,052	30,925	30,748	30,464	30,277	-	-
Announcement Date	3/17/22	4/13/23	3/14/24	3/13/25	3/12/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
KRKA, D. D.	17.65x	3.2x	11.1x	3.78%	8.46B
ELI LILLY AND COMPANY	39.94x	13.51x	30.01x	0.5%	1,216B
JOHNSON & JOHNSON	39.86x	6.69x	18.83x	1.96%	656B
ABBVIE INC.	37.08x	8.43x	17.39x	2.4%	509B
ROCHE HOLDING AG	21.12x	5.13x	12.77x	2.56%	384B
MERCK & CO., INC.	97.32x	5.95x	25.36x	2.32%	362B
NOVARTIS AG	23.5x	6.02x	14.53x	2.65%	311B
ASTRAZENECA PLC	24.85x	4.96x	13.98x	1.76%	293B
AMGEN INC.	28.41x	7.33x	12.69x	2.19%	249B
GILEAD SCIENCES, INC.	-40.11x	7.32x	45.99x	1.97%	208B
Average	28.96x	6.86x	20.26x	2.21%	419.63B
Weighted average by Cap.	35.84x	8.56x	22.21x	1.73%